Clinical Aspects of C-Type Natriuretic Peptide on the Cardiovascular System

Abstract

C-type natriuretic peptide (CNP) is one of the three most important members of the human natriuretic peptide family, sharing with them a highly conserved 17-aminoacid ring structure, essential to elicit its biological actions by binding to its specific receptor NPR-B. CNP acts in a paracrine or autocrine way and it is cleared from plasma circulation by the NPR-C receptor. This is one of the reasons why its plasma levels are usually low. CNP is widely spread in human tissues, being localized in a variety of cells such as cardiac and vascular smooth muscle cells, chondrocytes, macrophages, glial cells, and renal, brain and reproductive tissues. In the cardiovascular system, CNP is stored in endothelial cells and exert different actions like vasodilation in large conduction vessels, and anti-proliferative, pro-apoptotic, anti-fibrotic and anti-hypertrophic properties in cardiomyocytes; it also inhibits neointimal restenosis and reduces cardiac ischemia-reperfusion injury and vascular constrictive remodeling. In addition, it has been suggested that CNP acts as an endothelium derived hyperpolarizing factor as a consequence of its hyperpolarizing action in resistance arterial smooth vessels muscle. Regarding its clinical aspects, it has been demonstrated the relation between CNP and different cardiovascular pathologies such as heart failure, myocardial infarction, cardiac remodeling, arterial hypertension, angiogenesis and revascularization, restenosis, atherosclerosis, pulmonary hypertension, and myocardial aging.

Authors and Affiliations

Cantú Silvana M, Donoso Adriana S, Kouyoumdzian Nicolás M, Rukavina Mikusic Natalia L, Puyó Ana M, Choi Marcelo R

Keywords

Related Articles

Bilateral Painless Testicular Enlargement: An Unusual Presentation of Sarcoidosis and a Literature Review

Background: Sarcoidosis is a systemic inflammatory disease characterized by non-caseating epitheloid granulomas; whereas it usually involves the lungs and lymph nodes, genitourinary involvement is extremely rare. For thi...

Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases

Objectives: S100A8/A9 expression has been linked to carcinogenesis and inflammation. We hypothesized that S100A8/A9 protein serum levels are a useful stratification marker for patients with pancreatic ductal adenocarcino...

The Value of Positron Emission Tomography/Computerized Tomography Imaging in the Restaging of Differentiated Thyroid Cancers and Evaluation of its Association with Thyroglobulin Levels

Purpose: Recently, there have been an increasing number of studies indicating that Florine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a sensitive method in the evaluation of...

Diabetic Retinopathy: Focus on Minority Populations

Diabetic retinopathy is a major cause of blindness in the United States. With rise of the epidemic of obesity and diabetes in the USA and around the globe, serious and common diabetic complications are evolving as a majo...

Hyperparathyroidism and Asthenia. A New Deal?

The profile of primary hyperparathyroidism (PHPT) changed profoundly over the course of the twentieth century. The highly symptomatic forms reported in the 1960s have progressively been replaced by forms with few symptom...

Download PDF file
  • EP ID EP541686
  • DOI 10.17352/ijcem.000007
  • Views 58
  • Downloads 0

How To Cite

Cantú Silvana M, Donoso Adriana S, Kouyoumdzian Nicolás M, Rukavina Mikusic Natalia L, Puyó Ana M, Choi Marcelo R (2015). Clinical Aspects of C-Type Natriuretic Peptide on the Cardiovascular System. International Journal of Clinical Endocrinology and Metabolism, 1(1), 31-36. https://europub.co.uk/articles/-A-541686